bioavailability
Articles tagged with “bioavailability”
Subcutaneous Ketamine: Clinical Use, Onset, and Bioavailability
How subcutaneous ketamine works, its bioavailability vs IV, clinical settings where it's used, and questions to discuss with a licensed clinician.
Ketamine Onset Time by Route: What the Research Shows
How quickly does ketamine work? Onset ranges from 30 seconds (IV) to 30 minutes (oral). Compare bioavailability, duration, and supervision needs by route.
Compounded Ketamine vs Spravato: Key Differences Explained
Compare compounded ketamine and Spravato (esketamine): FDA approval, bioavailability, supervision requirements, and clinical access differences.
Rectal Ketamine Administration: Uses in Pediatric and Palliative Care
An educational overview of rectal ketamine administration, including its pharmacokinetics, clinical applications in pediatric sedation and palliative care, and how it compares to other routes.
First-Pass Metabolism: How Liver Processing Affects Oral Ketamine
A definition of first-pass metabolism — the hepatic processing that reduces oral drug bioavailability — and its specific impact on oral ketamine formulations.
IV Ketamine vs Oral Ketamine: Routes of Administration Compared
IV vs oral ketamine therapy compared by bioavailability, onset, dose ranges, monitoring, cost per session, and which route fits which patient situation.
Ketamine Pharmacology: Absorption, Distribution, Metabolism
Ketamine pharmacology explained: absorption by route, distribution, hepatic metabolism to norketamine, half-life, enantiomers, and clinical dosing implications.
Bioavailability: Understanding Ketamine Absorption by Route
A clear explanation of bioavailability and how it varies across ketamine administration routes — IV, IM, intranasal, sublingual, and oral — and why it matters.
Contact Ketamine Resource
Send corrections, partnership questions, or advertising inquiries.